Skip to Main Content
Table 1 —

Predialysis clinical characteristics of surviving and nonsurviving diabetic subjects on hemodialysis

SurvivorsNonsurvivorsP
n (% Male) 36 (72.2) 114 (72.8) 0.999 
Age at hemodialysis initiation (years) 56.9 ± 10.5 61.7 ± 9.9 0.013* 
SBP (mmHg) 167 ± 19 159 ± 22 0.052 
DBP (mmHg) 83 ± 10 82 ± 14 0.580 
BMI (kg/m223.4 ± 3.2 22.0 ± 3.6 0.086 
CTR (%) 51.7 ± 5.3 53.9 ± 6.6 0.061 
HbA1c (%) 6.7 ± 1.3 7.5 ± 2.1 0.031* 
Cre (mg/dl) 9.9 ± 3.3 8.5 ± 3.0 0.015* 
Na (mEq/l) 138 ± 5 136 ± 7 0.149 
K (mEq/l) 4.5 ± 0.8 4.4 ± 0.9 0.721 
TP (g/dl) 6.4 ± 0.7 6.3 ± 0.8 0.494 
Hb (g/dl) 7.9 ± 1.5 7.9 ± 1.5 0.981 
T-chol (mg/dl) 203 ± 80 185 ± 62 0.149 
SurvivorsNonsurvivorsP
n (% Male) 36 (72.2) 114 (72.8) 0.999 
Age at hemodialysis initiation (years) 56.9 ± 10.5 61.7 ± 9.9 0.013* 
SBP (mmHg) 167 ± 19 159 ± 22 0.052 
DBP (mmHg) 83 ± 10 82 ± 14 0.580 
BMI (kg/m223.4 ± 3.2 22.0 ± 3.6 0.086 
CTR (%) 51.7 ± 5.3 53.9 ± 6.6 0.061 
HbA1c (%) 6.7 ± 1.3 7.5 ± 2.1 0.031* 
Cre (mg/dl) 9.9 ± 3.3 8.5 ± 3.0 0.015* 
Na (mEq/l) 138 ± 5 136 ± 7 0.149 
K (mEq/l) 4.5 ± 0.8 4.4 ± 0.9 0.721 
TP (g/dl) 6.4 ± 0.7 6.3 ± 0.8 0.494 
Hb (g/dl) 7.9 ± 1.5 7.9 ± 1.5 0.981 
T-chol (mg/dl) 203 ± 80 185 ± 62 0.149 

Data are n (%) or means ± SD.

*

P < 0.05.

Close Modal

or Create an Account

Close Modal
Close Modal